Author
Hui Lin Ou
0 works0 citations
Recent research
- Health & MedicineOpen access
Background: Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) have transformed lung cancer therapy, but their efficacy is often limited in tumors with low programmed cell death ligand 1 (PD-L1) expression and immunologically “cold” tumor microenvironme...